Seizert Capital Partners’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
OAM
Seizert Capital Partners's ASTH Position: Q1 2022 in Review
Seizert Capital Partners sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 8,551 shares — an estimated $628K sold.
Seizert Capital Partners first reported a position in ASTH in Q4 2020 and held it in 5 quarters. The position peaked at $1.28M in Q2 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.
- Seizert Capital Partners reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
- Seizert Capital Partners sold 8,551 Astrana Health shares in Q1 2022, an estimated $628K.
- Seizert Capital Partners first reported a position in Astrana Health in Q4 2020 and held it in 5 quarters.
- Seizert Capital Partners's Astrana Health position peaked at $1.28M in Q2 2021.
- 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.
Based on Seizert Capital Partners's 13F filing for Q1 2022, filed 3 May 2022.